2005
DOI: 10.1167/iovs.05-0129
|View full text |Cite
|
Sign up to set email alerts
|

Leukemia Inhibitory Factor Blocks Expression of Crx and Nrl Transcription Factors to Inhibit Photoreceptor Differentiation

Abstract: LIF expression did not appear to alter photoreceptor cell fate specification, but it inhibited subsequent differentiation. These results suggest that gp130 ligands can inhibit photoreceptor functional differentiation by reducing Crx- and Nrl-dependent transcription.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
32
0

Year Published

2005
2005
2019
2019

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 34 publications
(38 citation statements)
references
References 64 publications
6
32
0
Order By: Relevance
“…Consequently, inhibition of rod differentiation by LIF was sustained in explants grown for a maximum of 12 days. Moreover, overexpression of LIF in the mouse eye results in an almost complete suppression of rod differentiation throughout the period of retinal development (Graham et al 2005). Taken together, these results support the hypothesis that rod development in vivo is transiently inhibited by a CNTFRα-mediated signal, the action of which is then terminated by the downregulation of the receptor to permit terminal differentiation.…”
Section: Responsiveness Of Developing Photoreceptors To Gp130-associasupporting
confidence: 71%
See 1 more Smart Citation
“…Consequently, inhibition of rod differentiation by LIF was sustained in explants grown for a maximum of 12 days. Moreover, overexpression of LIF in the mouse eye results in an almost complete suppression of rod differentiation throughout the period of retinal development (Graham et al 2005). Taken together, these results support the hypothesis that rod development in vivo is transiently inhibited by a CNTFRα-mediated signal, the action of which is then terminated by the downregulation of the receptor to permit terminal differentiation.…”
Section: Responsiveness Of Developing Photoreceptors To Gp130-associasupporting
confidence: 71%
“…However, this does not exclude the existence of such a mechanism in vivo that might crucially depend on the effective concentrations of the factors. The overexpression of LIF in the eyes of transgenic mice has recently shown that cytokine signaling during postnatal retinal development inhibits not only the expression of phototransduction components, representing markers for terminally differentiated photoreceptors, but also that of key transcription factors, such as crx, nrl and Nr2e3, which are required for the phenotypic maturation of the progenitor cells (Graham et al 2005). These results indicate that the action of CNTF-like cytokines arrests developing photoreceptor at a precursor cell state and suggest that the downregulation of CNTFRα is a precondition for the initiation of terminal photoreceptor differentiation.…”
Section: Regulation Of Cntf Receptor Expressionmentioning
confidence: 99%
“…We generated populations in which all the cell aggregates contained Crx-positive cells ( 65% of Following the scale up of the ESC differentiation protocol to isolate populations for transplantation, we found very few Nrl expressing cells. This may be due to several reasons including increased concentrations of inhibitory factors derived from other retinal cell types, such as ciliary neurotrophic factor produced by astrocytes and glial cells [26][27][28][29], and previously shown to inhibit rod differentiation [30,31] and to block Nrl and Crx expression [32]. In vivo retinal development involves gradients of secreted signaling molecules, such as fibroblast growth factor (FGF) 2 and Shh [33], that may not be present in the adherent ESC-derived cultures.…”
Section: Discussionmentioning
confidence: 99%
“…However, little is known regarding the mechanism of protection. In addition, several adverse consequences of overstimulation of this receptor have been reported, including gliosis (38), inhibition of neural function (17,19,39,40), and altered developmental states (41)(42)(43). Therefore, specific knowledge of the mechanism for gp130-induced protection is essential for the development of neuroprotective therapies to avoid these side effects.…”
Section: Discussionmentioning
confidence: 99%